argenx SE | Investor Presentation Deck | 22 slides · page 13 of 22
The slide uses a timeline structure to map clinical development stages against specific disease indications and their associated U.S. patient prevalence numbers.
Conference presentation · timeline · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 list 1/1 source-note 1/1 title 1/1
Components 4
timeline bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1